Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Oren Livnat Maintained (ANIP) at Strong Buy with Increased Target to $87 on, May 13th, 2024
Oren Livnat of HC Wainwright & Co., Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $83 to $87 on, May 13th, 2024.
Oren has made no other calls on ANIP in the last 4 months.
There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Oren's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Oren
- Vamil Divan of "Guggenheim" Reiterated at Strong Buy and Held Target at $77 on, Tuesday, April 23rd, 2024
- Timothy Chiang of "Capital One" Initiated at Buy on, Friday, March 15th, 2024
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024
Contributing Sources